ING Group’s Sabra Healthcare REIT SBRA Stock Holding History

ING Group’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-27,110	Closed	-$478K	–	841
2018 Q1	$478K	Buy	+27,110	New	+$478K	0.01%	484
2017 Q4	–	Sell	-21,537	Closed	-$473K	–	879
2017 Q3	$473K	Buy	+21,537	New	+$487K	0.01%	500

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ING Group's SBRA Position: Q2 2018 in Review

ING Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2018, closing a stake of 27,110 shares — an estimated $478K sold.

ING Group first reported a position in SBRA in Q3 2017 and held it in 2 quarters. The position peaked at $478K in Q1 2018. 330 funds tracked by Wall St. Rank hold SBRA as of Q2 2018.

ING Group reported no remaining Sabra Healthcare REIT position as of Q2 2018 after selling out during the quarter.
ING Group sold 27,110 Sabra Healthcare REIT shares in Q2 2018, an estimated $478K.
ING Group first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 2 quarters.
ING Group's Sabra Healthcare REIT position peaked at $478K in Q1 2018.
330 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2018.

Based on ING Group's 13F filing for Q2 2018, filed 10 Aug 2018.